ProMIS Neurosciences, Inc. (PMN)

19.89 +1.93 (+10.75%) USD  |  NASDAQ  |  Feb 25, 13:03
More

ProMIS Neurosciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for PMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade